Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp. is a biotechnology company specializing in the research and development of treatments for psychiatric and neurological disorders. The company's revenue streams are derived from the discovery and commercialization of novel therapies for these conditions. Additionally, Pasithea Therapeutics Corp. plans to generate income through the operation of anti-depression clinics, offering intravenous ketamine infusions administered by trained pharmacists. These services are expected to contribute to the company's overall business model, providing support and treatment options for individuals suffering from mental health disorders.